Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Informatics, Genzyme Sign Licensing Agreement for BioMerge

Premium

SANTA FE, NM--Molecular Informatics Inc., a bioinformatics software company here, has signed a deal with Genzyme Corp. to license Molecular Informatics's BioMerge software to enhance and support the Multiple Allele-Specific Diagnostic Assay (MASDA) and Serial Analysis of Gene Expression (SAGE) products offered by two Genzyme subsidiaries.

BioMerge combines object-oriented and relational database technologies in an enterprise-wide software system used to process, manage, integrate, and analyze genomic information. The agreement also gives Genzyme early access to Molecular Informatics technology, consulting, and product services.

MASDA is used to analyze multiple patient DNA samples for hundreds of mutations on one or more genes at the same time. SAGE is a genomics tool that detects and quantitates gene expression levels in different tissues. BioMerge will help compare the genetic data generated by MASDA and SAGE to that in public genomic databases.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.